Yamada’s Textbook of Gastroenterology

Sixth Edition

Edited by Daniel K. Podolsky,
Michael Camilleri, J. Gregory Fitz,
Anthony N. Kalloo, Fergus Shanahan, Timothy C. Wang

References

Esophageal infections and disorders associated with acquired immunodefi ciency syndrome

1. MonkemullerKE, CallSA, LazenbyAJ, et al.Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol2000;95:457. CrossRef

2. SchwarczL, ChenM, VittinghoffE, et al.Declining incidence of AIDS‐defining opportunistic illnesses: results from 16 years of population‐based AIDS surveillance. AIDS2013;27:597. CrossRef

3. KottonCN. CMV: prevention, diagnosis and therapy. Am J Transplant2013;13:24. CrossRef

4. MimidiaK, PapadopoulosV, MargaritisV, et al.Predisposing factors and clinical symptoms in HIV‐negative patients with Candida oesophagitis: are they always present?Int J Clin Pract2005;59:210. CrossRef

5. Canalejo CastrilleroE, Garcia DuránF, CabelloN, et al.Herpes esophagitis in healthy adults and adolescents: report of 3 cases and review of the literature. Medicine (Baltimore)2010;89:204. CrossRef

6. ChiuLM, DomagalaBM, ParkJM. Management of opportunistic infections in solid‐organ transplantation. Prog Transplant2004;14:114. CrossRef

7. WilcoxCM, AlexanderLN, ClarkWS, et al.Fluconazole compared with endoscopy for human immunodeficiency virus‐infected patients with esophageal symptoms. Gastroenterology1996;110:1803. CrossRef

8. WilcoxCM, SchwartzDA. Endoscopic‐pathologic correlates of Candida esophagitis in acquired immunodeficiency syndrome. Dig Dis Sci1996;41:1337. CrossRef

9. WilcoxCM, StraubRF, ClarkWS. Prospective evaluation of oropharyngeal findings in human immunodeficiency virus‐infected patients with esophageal ulceration. Am J Gastroenterol1995;90:1938.

10. RobertsLJr, GibbonsR, GibbonsG, et al.Adult esophageal candidiasis: a radiographic spectrum. Radiographics1987;7:289. CrossRef

11. WilcoxCM, StraubRF, AlexanderLN, et al.Etiology of esophageal disease in human immunodeficiency virus‐infected patients who fail antifungal therapy. Am J Med1996;101:599. CrossRef

12. ChaR, SobelJD. Fluconazole for the treatment of candidiasis: 15 years experience. Expert Rev Anti Infect Ther2004;2:357. CrossRef

13. LortholaryO, PetrikkosG, AkovaM, et al.ESCMID guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect2012;18:68. CrossRef

14. BarbariG, BarbariniG, CalderonW, et al.Fluconazole versus itraconazole for Candida esophagitis in acquired immunodeficiency syndrome. Gastroenterology1996;111:1169. CrossRef

15. ChenSC, SlavinMA, SorrellTC. Echinocandin antifungal drugs in fungal infections: a comparison. Drugs2011;71:11. CrossRef

16. ShohamS, MarrKA. Invasive fungal infections in solid organ transplant recipients. Future Microbiol2012;7:639. CrossRef

17. VazquezJA, SkiestDJ, Tissot‐DupontH, et al.Safety and efficacy of posaconazole in the long‐term treatment of azole‐refractory oropharyngeal and esophageal Candidiasis in patients with HIV infection. HIV Clin Trials2007;8:86. CrossRef

18. BaehrPH, McDonaldGB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology1994;106:509.

19. KahiCJ, WheatLJ, AllenSD, et al.Gastrointestinal histoplasmosis. Am J Gastroenterol2005;100:220. CrossRef

20. McKenzieR, KhakooR. Blastomycosis of the esophagus presenting with gastrointestinal bleeding. Gastroenterology1985;88:1271.

21. MargolisPS, EpsteinA. Mucormycosis esophagitis in a patient with the acquired immunodeficiency syndrome. Am J Gastroenterol1994;89:1900.

22. AsanzaCG, MenchenPL, SenentC, et al.Esophageal aspergillosis: an unusual endoscopic finding. Endoscopy2000;32:S7.

23. JeuL, PiacentiFJ, LyakhovetskiyAG, et al.Voriconazole. Clin Ther2003;25:1321. CrossRef

24. MonkemullerKE, LazenbyAJ, LeeDH, et al.Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy. Dig Dis Sci2005;50:230. CrossRef

25. WilcoxCM, SchwartzDA, ClarkWS. Esophageal ulceration in human immunodeficiency virus infection: causes, diagnosis, and management. Ann Intern Med1995;123:143. CrossRef

26. LevineMS, RubesinSE, LauferI. Barium esophagography: a study for all seasons. Clin Gastroenterol Hepatol2008;6:11. CrossRef

27. McBaneRD, GrossJRJr. Herpes esophagitis: clinical syndrome, endoscopic appearance, and diagnosis in 23 patients. Gastrointest Endosc1991;37:600. CrossRef

28. GenereauT, LortholaryO, BouchaudO, et al.Herpes simplex esophagitis in patients with AIDS: report of 34 cases. Clin Infect Dis1996;22:926. CrossRef

29. BradyRC, BernsteinDI. Treatment of herpes simplex virus infections. Antiviral Res2004;61:73. CrossRef

30. MorfinF, ThouvenotD. Herpes simplex virus resistance to antiviral drugs. J Clin Virol2003;26:29. CrossRef

31. MonkemullerKE, BussianAH, LazenbyAJ, et al.Special histologic stains are rarely beneficial for the evaluation of HIV‐related gastrointestinal infections. Am J Clin Pathol2000;114:387.

32. AltmanC, BedossaP, DuussaixE, et al.Cytomegalovirus infection of esophagus in immunocompetent adults. Dig Dis Sci1995;40:606. CrossRef

33. WilcoxCM, StraubRF, SchwartzDA. Cytomegalovirus esophagitis in AIDS: a prospective study of clinical response to ganciclovir therapy, relapse rate, and long‐term outcome. Am J Med1995;98:169. CrossRef

34. SugarEA, JabsDA, AhujaA, et al.Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol2012;153:1016. CrossRef

35. WilcoxCM. Esophageal strictures complicating ulcerative esophagitis in patients with AIDS. Am J Gastroenterol1999;94:339. CrossRef

36. ChalasaniN, ParkerKM, WilcoxCM. Bronchoesophageal fistula as a complication of cytomegalovirus esophagitis in AIDS. Endoscopy1997;29:S28. CrossRef

37. WilcoxCM, StraubRA, SchwartzDA. Prospective endoscopic characterization of cytomegalovirus esophagitis in patients with AIDS. Gastrointest Endosc1994;40:481. CrossRef

38. PiiparinenH, HelanteraI, LappalainenM, et al.Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients. J Med Virol2005;76:367. CrossRef

39. WilcoxCM, StraubRF, SchwartzDA. A prospective evaluation of biopsy number for the diagnosis of viral esophagitis in patients with HIV infection and esophageal ulcer. Gastrointest Endosc1996;44:587. CrossRef

40. WilcoxCM, RodgersW, LazenbyA. Prospective comparison of brush cytology, viral culture, and histology for the diagnosis of ulcerative esophagitis in AIDS. Clin Gastroenterol Hepatol2004;2:564. CrossRef

41. AchenbachCJ, HarringtonRD, DhanireddyS, et al.Paradoxical immune reconstitution inflammatory syndrome in HIV‐infected patients treated with combination antiretroviral therapy after AIDS‐defining opportunistic infection. Clin Infect Dis2012;54:424. CrossRef

42. LePageAK, JagerMM, IwasenkoJM, et al.Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients. Clin Infect Dis2013; 56:1018. CrossRef

43. WiltshireH, HirankarnS, FarrellC, et al.Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet2005;44:495. CrossRef

44. AndrewsPA, EmeryVC, NewsteadC. Summary of the British Transplantation Society Guidelines for the prevention and management of CMV disease after solid organ transplantation. Transplantation2011;92:1181. CrossRef

45. BoivinG, GoyetteN, GilbertC, et al.Absence of cytomegalovirus‐resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid‐organ transplant recipients. J Infect Dis2004;189:1615. CrossRef

46. FishmanJA. Overview: cytomegalovirus and the herpesviruses in transplantation. Am J Transplant2013;13:1. CrossRef

47. QiZ, JiangQ, YangJ, et al.Human papillomavirus (HPV) infection and the risk of esophageal squamous cell carcinoma. Dis Esophagus2013;26:61. CrossRef

48. ChangAD, DrachenbergCI, JamesSP. Bacillary angiomatosis associated with extensive esophageal polyposis: a new mucocutaneous manifestation of acquired immunodeficiency disease (AIDS). Am J Gastroenterol1996;91:2220.

49. PorterJC, FriedlandJS, FreedmanAR. Tuberculosis bronchoesophageal fistulae in patients infected with the human immunodeficiency virus: three case reports and review. Clin Infect Dis1994;19:954. CrossRef

50. NagiB, LalA, KochharR. Imaging of esophageal tuberculosis: a review of 23 cases. Acta Radiol2003; 220;44:329.

51. LeungVK, ChanWH, ChowTL, et al.Oesophageal tuberculosis mimicking oesophageal carcinoma. Hong Kong Med J2006;12:473.

52. ShafranSD, SingerJ, ZarownyDP, et al.A comparision of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithroymcin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med1996;335:377. CrossRef

53. WalshTJ, BelitsosNJ, HamiltonSR. Bacterial esophagitis in immunocompromised patients. Arch Intern Med1986;146:1345. CrossRef

54. MurchanEM, Redelman‐SidiG, PatelM, et al.Esophageal actinomycosis in a fifty‐three‐year‐old man with HIV: case report and review of the literature. AIDS Patient Care STDS2010;24:73. CrossRef

55. PasquauF, EnaJ, SanchezR, et al.Leishmaniasis as an opportunistic infection in HIV‐infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region. Eur J Clin Microbiol Infect Dis2005;24:411. CrossRef

56. BernC, KjosS, Yabsley, et al. Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev2011; 24:655. CrossRef

57. KjosSA, SnowdenKF, OlsonJK.Biogeography and Trypanosoma cruzi infection prevalence of Chagas disease vectors in Texas, USA. Vector Borne Zoonotic Dis2009;9:41. CrossRef

58. RicheyLE, HalperinJ. Acute human immunodeficiency virus infection. Am J Med Sci2013;345:136. CrossRef

59. WilcoxCM, SchwartzDA. Endoscopic characterization of idiopathic esophageal ulceration associated with human immunodeficiency virus infection. J Clin Gastroenterol1993;16:251. CrossRef

60. WilcoxCM. Evaluation of a technique to evaluate the underlying mucosa in patients with AIDS and severe Candida esophagitis. Gastrointest Endosc1995;42:360. CrossRef

61. WilcoxCM, ZakiSR, CoffieldLM, et al.Evaluation of idiopathic esophageal ulcer for human immunodeficiency virus. Mod Pathol1995;8:568.

62. FragerD, KotlerDP, BaerJ. Idiopathic esophageal ulceration in the acquired immunodeficiency syndrome: radiologic reappraisal in 10 patients. Abdom Imaging1994;19:2. CrossRef

63. WilcoxCM, SchwartzDA. Comparison of two corticosteroid regimens for the treatment of idiopathic esophageal ulcerations associated with HIV infection. Am J Gastroenterol1994;89:2163.

64. AlexanderLN, WilcoxCM. A prospective trial of thalidomide for the treatment of HIV‐associated idiopathic esophageal ulcers. AIDS Res Hum Retroviruses1997;13:301. CrossRef

65. HamadaY, NagataN, HondaH, et al.Idiopathic oropharyngeal and esophageal ulcers related to HIV infection successfully treated with antiretroviral therapy alone. Intern Med2013;52:393. CrossRef

66. Di LorenzoG, KonstantinopoulosPA, PantanowitzL, et al.Management of AIDS‐related Kaposi's sarcoma. Lancet Oncol2007;8:167. CrossRef

67. BeckPL, JohnG, SutherlandLR. HIV‐associated non‐Hodgkin's lymphoma of the gastrointestinal tract. Am J Gastroenterol1996;91:2377.

68. ChadhaKS, Hernandez‐IlizaliturriFJ, JavleM. Primary esophageal lymphoma: case series and review of the literature. Dig Dis Sci2006;51:77. CrossRef

69. BowerM, GazzardB, MandaliaS, et al.A prognostic index for systemic AIDS‐related non‐Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med2005;143:265. CrossRef

70. PerssonEC, ShielsMS, DawseySM, et al.Increased risk of stomach and esophageal malignancies in people with AIDS. Gastroenterology2012;143:943. CrossRef